Rhythm Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
126.95 |
175.87 |
303.76 |
545.24 |
953.06 |
1,400.63 |
| Przychód Δ r/r |
0.00% |
38.53% |
72.72% |
79.50% |
74.80% |
46.96% |
| Przychód (min) |
126.01 |
159.45 |
231.40 |
545.24 |
815.86 |
1,199.00 |
| Przychód (max) |
128.05 |
202.03 |
400.00 |
545.24 |
1,143.26 |
1,680.16 |
| EBITDA (średnia) |
-76.17 |
-105.52 |
-182.26 |
-327.14 |
-571.83 |
-840.38 |
| EBIT (średnia) |
-76.17 |
-105.52 |
-182.26 |
-327.14 |
-571.83 |
-840.38 |
| EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-263.04 |
-172.43 |
-95.39 |
121.21 |
322.68 |
562.05 |
| Zysk netto % |
-207.19% |
-98.05% |
-31.40% |
22.23% |
33.86% |
40.13% |
| EPS (średnia) |
-4.32 |
-2.83 |
-1.59 |
1.07 |
5.29 |
9.21 |
| Liczba analityków (Przychody) |
10 |
12 |
14 |
10 |
4 |
5 |
| Liczba analityków (EPS) |
9 |
10 |
11 |
7 |
5 |
2 |
| symbol |
RYTM |
RYTM |
RYTM |
RYTM |
RYTM |
RYTM |